Entity usage

This page lists pages that use the given entity (e.g. Q42). The list is sorted by descending page ID, so that newer pages are listed first.

Showing below up to 18 results in range #1 to #18.

Non-inferiority tests for anti-infective drugs using control group quantiles: Label: en
Dose-finding design for multi-drug combinations: Label: en
A predictive probability design for phase II cancer clinical trials: Label: en
Bayesian hierarchical modeling of patient subpopulations: Efficient designs of Phase II oncology clinical trials: Label: en
A modified toxicity probability interval method for dose-finding trials: Label: en
Marker Sequential Test (MaST) design: Label: en
Sensitivity analysis of causal inference in a clinical trial subject to crossover: Label: en
Summarizing historical information on controls in clinical trials: Label: en
Summarizing the incidence of adverse events using volcano plots and time intervals: Label: en
The Bayesian Time Machine: Accounting for temporal drift in multi-arm platform trials: Label: en
A simulation study of outcome adaptive randomization in multi-arm clinical trials: Label: en
Variance prior specification for a basket trial design using Bayesian hierarchical modeling: Label: en
Dose-finding in phase I clinical trials based on toxicity probability intervals: Label: en
The maraca plot: A novel visualization of hierarchical composite endpoints: Label: en
Network meta-analysis of randomized clinical trials: Reporting the proper summaries: Label: en
A permutation procedure to detect heterogeneous treatment effects in randomized clinical trials while controlling the type I error rate: Label: en
Imputation methods for missing outcome data in meta-analysis of clinical trials: Label: en
Event-specific win ratios and testing with terminal and non-terminal events: Label: en